Bilateral uveitis associated with nivolumab therapy
Sign Up to like & getrecommendations! Published in 2018 at "Journal francais d'ophtalmologie"
DOI: 10.1016/j.jfo.2018.02.001
Abstract: New anticancer therapies, immune pathway inhibitors, may cause immune-related adverse events (IRAE). Immune-related ocular toxicities are rare but are potentially serious adverse events. The purpose of this article is to report a case of ocular… read more here.
Keywords: nivolumab therapy; uveitis associated; associated nivolumab; therapy ... See more keywords
Diffuse alveolar hemorrhage with pseudoprogression during nivolumab therapy in a patient with malignant melanoma
Sign Up to like & getrecommendations! Published in 2018 at "Thoracic Cancer"
DOI: 10.1111/1759-7714.12872
Abstract: Nivolumab, an anti‐PD‐1 antibody, has been shown to be effective in many cancers, such as malignant melanoma and lung cancer; however, nivolumab therapy can result in pseudoprogression. Diffuse alveolar hemorrhage (DAH) is persistent or recurrent… read more here.
Keywords: therapy; hemorrhage; nivolumab therapy; malignant melanoma ... See more keywords
Adjuvant nivolumab therapy may not improve disease‐free survival in resected acral lentiginous melanoma patients: A retrospective case series
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Therapy"
DOI: 10.1111/dth.15817
Abstract: Adjuvant nivolumab therapy has been reported to improve the survival of melanoma patients. Acral lentiginous melanoma (ALM) has been reported to be less likely to respond to immune checkpoint inhibitors (ICIs) than other subtypes. However,… read more here.
Keywords: nivolumab therapy; melanoma; survival; therapy ... See more keywords
Successful nivolumab therapy in an allogeneic stem cell transplant child with post‐transplant lymphoproliferative disorder
Sign Up to like & getrecommendations! Published in 2018 at "Pediatric Transplantation"
DOI: 10.1111/petr.13302
Abstract: Primary CNS PTLD is an extremely rare complication after allogeneic HSCT. At our centre, an 11‐year‐old patient developed nausea, vomiting, and diplopy on day +82 following HSCT. On brain MRI, multiple white matter lesions were… read more here.
Keywords: therapy allogeneic; successful nivolumab; nivolumab therapy; therapy ... See more keywords
Delayed Presentation of Isolated Adrenocorticotropin Insufficiency after Nivolumab Therapy for Advanced Non-small-cell lung carcinoma (NSCLC)
Sign Up to like & getrecommendations! Published in 2018 at "BMJ Case Reports"
DOI: 10.1136/bcr-2018-225048
Abstract: We describe a 73-year-old man who developed adrenal insufficiency 7 months after completing nivolumab therapy for advanced non-small cell lung cancer. He presented with non-specific symptoms of malaise and fatigue with an insidious 13.6 kilogram weight… read more here.
Keywords: advanced non; nivolumab therapy; therapy advanced; non small ... See more keywords
Neurologic Complications: Effects of Ipilimumab and Nivolumab Therapy in Patients With Metastatic Melanoma.
Sign Up to like & getrecommendations! Published in 2019 at "Clinical journal of oncology nursing"
DOI: 10.1188/19.cjon.355-358
Abstract: Checkpoint inhibitors are a form of immunotherapy that have revolutionized treatment for malignant melanoma, resulting in longer survival and better disease control. Multiple autoimmune disorders can occur with the use of checkpoint inhibitors, including severe,… read more here.
Keywords: therapy patients; complications effects; effects ipilimumab; ipilimumab nivolumab ... See more keywords